Exposure to Selective Serotonin Reuptake Inhibitors in Early Pregnancy and the Risk of Miscarriage
Authors:
- Jon Trærup AndersenJAJon Trærup Andersen
- Nadia Lyhne AndersenNANadia Lyhne Andersen
- Henrik HorwitzHHHenrik Horwitz
- Henrik Enghusen PoulsenHPHenrik Enghusen Poulsen
- Espen Jimenez-SolemEJEspen Jimenez-Solem
- 1 October 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 124 (4) , 655-661
Abstract
To investigate whether exposure to selective serotonin reuptake inhibitors (SSRIs) in early pregnancy is associated with miscarriage. This was a nationwide cohort study identifying all registered pregnancies in Denmark from 1997 to 2010. All births were identified using the Medical Birth Registry, and all records of induced abortion or miscarriage were gathered from the National Hospital Register. Data on SSRI use were gathered from the National Prescription Register. Cox proportional hazard regression models were used to calculate the hazard of miscarriage in women exposed to an SSRI in early pregnancy and the hazard of miscarriage in women discontinuing treatment before pregnancy. We identified 1,279,840 pregnancies (911,569 births, 142,093 miscarriages, 226,178 induced abortions). Of the 22,884 exposed to an SSRI during the first 35 days of pregnancy, 12.6% (2,883) ended in miscarriage compared with 11.1% among unexposed. The adjusted hazard ratio of having a miscarriage after exposure to an SSRI was 1.27 (95% confidence interval [CI] 1.22-1.33) compared with unexposed. Women discontinuing SSRI treatment 3-12 months before pregnancy also had an increased hazard ratio of having a miscarriage compared to unexposed (1.24, 95% CI 1.18-1.30). Women exposed to SSRIs during early pregnancy were at increased risk of miscarriage as were women discontinuing SSRI treatment before pregnancy, and these risks were similar. Therefore, treatment with SSRIs during pregnancy should not be discontinued as a result of fear of miscarriage. LEVEL OF EVIEDENCE:: II.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort StudyPLOS ONE, 2013
- Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant MedicationJAMA Psychiatry, 2013
- La dépression de l’antepartum : prévalence, diagnostic, traitementL'Encéphale, 2010
- Remission of maternal depression and child symptoms among single mothersSocial Psychiatry and Psychiatric Epidemiology, 2007
- Perinatal Risks of Untreated Depression during PregnancyThe Canadian Journal of Psychiatry, 2004
- Prevalence of Depression During Pregnancy: Systematic ReviewObstetrics & Gynecology, 2004
- Birth Outcomes in Pregnant Women Taking FluoxetineNew England Journal of Medicine, 1996
- The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)Reproductive Toxicology, 1996
- Pregnancy Outcome Following First-Trimester Exposure to Fluoxetine (Prozac)JAMA, 1993
- 5-Hydroxytryptamine (serotonin), copper and ceruloplasmin plasma concentrations in spontaneous abortionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1979